{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:57:30Z","timestamp":1760853450129,"version":"3.44.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.cbi.2010.02.002","type":"journal-article","created":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T09:53:01Z","timestamp":1265709181000},"page":"42-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Factors determining sensitivity or resistance of tumor cell lines towards artesunate"],"prefix":"10.1016","volume":"185","author":[{"given":"Serkan","family":"Sertel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolga","family":"Eichhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter K.","family":"Plinkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cbi.2010.02.002_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/1541-7786.MCR-06-0404","article-title":"The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents","volume":"5","author":"Tabernero","year":"2007","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.cbi.2010.02.002_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0006-2952(03)00341-1","article-title":"Identification of gene expression profiles predicting tumor cell response to l-alanosine","volume":"66","author":"Efferth","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/bcmd.2002.0483","article-title":"Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells","volume":"28","author":"Efferth","year":"2002","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cbi.2010.02.002_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-4020-6554-5_13","article-title":"Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis","volume":"615","author":"Shankar","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.cbi.2010.02.002_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1021\/np034072q","article-title":"Sesquiterpene lactones from Montanoa hibiscifolia that inhibit the transcription factor NF-kappa B","volume":"67","author":"Muller","year":"2004","journal-title":"J. Nat. Prod."},{"issue":"8","key":"10.1016\/j.cbi.2010.02.002_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2007.07.001","article-title":"From traditional Chinese medicine to rational cancer therapy","volume":"13","author":"Efferth","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.cbi.2010.02.002_bib7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bcp.2004.12.003","article-title":"Molecular modes of action of cantharidin in tumor cells","volume":"69","author":"Efferth","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2010.02.002_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1749-8546-2-8","article-title":"Molecular biology of cantharidin in cancer cells","volume":"2","author":"Rauh","year":"2007","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-1999-13953","article-title":"Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor","volume":"65","author":"Yim","year":"1999","journal-title":"Planta Med."},{"issue":"5548","key":"10.1016\/j.cbi.2010.02.002_bib10","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.294.5548.1834b","article-title":"Research on resistance to cancer drug Gleevec","volume":"294","author":"Sawyers","year":"2001","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.cbi.2010.02.002_bib11","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.2174\/092986707781368441","article-title":"Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine","volume":"14","author":"Efferth","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib12","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1371\/journal.pone.0000693","article-title":"Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells","volume":"2","author":"Efferth","year":"2007","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib13","first-page":"196","article-title":"Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs","volume":"46","author":"Efferth","year":"1996","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"10.1016\/j.cbi.2010.02.002_bib14","first-page":"459","article-title":"Microarray-based prediction of cytotoxicity of tumor cells to cantharidin","volume":"13","author":"Efferth","year":"2005","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.cbi.2010.02.002_bib15","first-page":"767","article-title":"The anti-malarial artesunate is also active against cancer","volume":"18","author":"Efferth","year":"2001","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.cbi.2010.02.002_bib16","first-page":"1231","article-title":"Role of antioxidant genes for the activity of artesunate against tumor cells","volume":"23","author":"Efferth","year":"2003","journal-title":"Int. J. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2010.02.002_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drup.2005.04.003","article-title":"Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy","volume":"8","author":"Efferth","year":"2005","journal-title":"Drug Resist. Updat."},{"issue":"3","key":"10.1016\/j.cbi.2010.02.002_bib18","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2010.02.002_bib19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J","article-title":"Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia","volume":"18","author":"Foley","year":"1965","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.cbi.2010.02.002_bib20","first-page":"5653","article-title":"Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells","volume":"56","author":"Hori","year":"1996","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.cbi.2010.02.002_bib21","first-page":"5137","volume":"61","author":"Alas","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib22","first-page":"149","article-title":"Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate","volume":"35","author":"Sieber","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.cbi.2010.02.002_bib23","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1073\/pnas.91.10.4382","article-title":"Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7","volume":"91","author":"Demers","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.cbi.2010.02.002_bib24","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1128\/jvi.66.4.2125-2134.1992","article-title":"The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells","volume":"66","author":"Halbert","year":"1992","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.cbi.2010.02.002_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J. Cell. Biol."},{"issue":"16","key":"10.1016\/j.cbi.2010.02.002_bib26","first-page":"4226","article-title":"In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833","volume":"51","author":"Boesch","year":"1991","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.cbi.2010.02.002_bib27","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bcp.2007.01.027","article-title":"Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein","volume":"73","author":"Storch","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1124\/jpet.107.122994","article-title":"Localization of the human breast cancer resistance protein (BCRP\/ABCG2) in lipid rafts\/caveolae and modulation of its activity by cholesterol in vitro","volume":"323","author":"Storch","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.cbi.2010.02.002_bib29","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.bcp.2004.08.026","article-title":"In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins","volume":"68","author":"Frohlich","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.102.046532","article-title":"Inhibition of P-glycoprotein by newer antidepressants","volume":"305","author":"Weiss","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkl474","article-title":"Modulation of human BCRP (ABCG2) activity by anti-HIV drugs","volume":"59","author":"Weiss","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cbi.2010.02.002_bib32","unstructured":"http:\/\/dtp.nci.nih.gov."},{"issue":"14","key":"10.1016\/j.cbi.2010.02.002_bib33","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/81.14.1088","article-title":"Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm","volume":"81","author":"Paull","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"issue":"16","key":"10.1016\/j.cbi.2010.02.002_bib34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/jnci\/86.16.1239","article-title":"Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen","volume":"86","author":"Leteurtre","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"issue":"14","key":"10.1016\/j.cbi.2010.02.002_bib35","first-page":"3199","article-title":"Reversible, p16-mediated cell cycle arrest as protection from chemotherapy","volume":"56","author":"Stone","year":"1996","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cbi.2010.02.002_bib36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/73439","article-title":"A gene expression database for the molecular pharmacology of cancer","volume":"24","author":"Scherf","year":"2000","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.cbi.2010.02.002_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0006-2952(02)01221-2","article-title":"mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether","volume":"64","author":"Efferth","year":"2002","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/genetics\/123.2.281","article-title":"Antibiotic resistance mutations in the chloroplast 16S and 23S rRNA genes of Chlamydomonas reinhardtii: correlation of genetic and physical maps of the chloroplast genome","volume":"123","author":"Harris","year":"1989","journal-title":"Genetics"},{"issue":"23","key":"10.1016\/j.cbi.2010.02.002_bib39","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1128\/MCB.22.23.8101-8113.2002","article-title":"Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation","volume":"22","author":"Stolovich","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib40","first-page":"292","article-title":"Effect of ribosomal protein L6 on drug resistance and apoptosis in K562\/A02 cells","volume":"15","author":"Chen","year":"2007","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4161\/cbt.4.2.1477","article-title":"Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells","volume":"4","author":"Du","year":"2005","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.cbi.2010.02.002_bib42","first-page":"1345","article-title":"Targeting beta1 integrin restores sensitivity to docetaxel of esophageal squamous cell carcinoma","volume":"20","author":"Mori","year":"2008","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/35052082","article-title":"Filamins as integrators of cell mechanics and signalling","volume":"2","author":"Stossel","year":"2001","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.cbi.2010.02.002_bib44","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1172\/JCI39542","article-title":"Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer","volume":"119","author":"Li","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2010.02.002_bib45","doi-asserted-by":"crossref","first-page":"d376","DOI":"10.2741\/grant","article-title":"Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival","volume":"7","author":"Grant","year":"2002","journal-title":"Front. Biosci."},{"issue":"8","key":"10.1016\/j.cbi.2010.02.002_bib46","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib47","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/mol.64.2.382","article-title":"Molecular modes of action of artesunate in tumor cell lines","volume":"64","author":"Efferth","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/156800909787314020","article-title":"The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunate's activity in cancer cells","volume":"9","author":"Konkimalla","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"issue":"5","key":"10.1016\/j.cbi.2010.02.002_bib49","first-page":"1246","article-title":"Isolation of a novel gene, CABC1, encoding a mitochondrial protein that is highly homologous to yeast activity of bc1 complex","volume":"62","author":"Iiizumi","year":"2002","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cbi.2010.02.002_bib50","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/pmic.200800633","article-title":"Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line","volume":"9","author":"Keenan","year":"2009","journal-title":"Proteomics"},{"issue":"4","key":"10.1016\/j.cbi.2010.02.002_bib51","first-page":"344","article-title":"Identification of mutations in protein kinase CKIIbeta subunit that affect its binding to ribosomal protein L41 and homodimerization","volume":"36","author":"Ahn","year":"2003","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.cbi.2010.02.002_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6605307","article-title":"Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells","author":"Ueno","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.cbi.2010.02.002_bib53","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/ijc.22804","article-title":"Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt\/beta-catenin pathway","volume":"121","author":"Li","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.niox.2008.04.008","article-title":"Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells","volume":"19","author":"Konkimalla","year":"2008","journal-title":"Nitric Oxide"},{"issue":"57","key":"10.1016\/j.cbi.2010.02.002_bib55","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1038\/sj.onc.1210059","article-title":"Colorectal cancer and genetic alterations in the Wnt pathway","volume":"25","author":"Segditsas","year":"2006","journal-title":"Oncogene"},{"issue":"12 Pt 1","key":"10.1016\/j.cbi.2010.02.002_bib56","first-page":"2415","article-title":"Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel","volume":"3","author":"Grim","year":"1997","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00001622-199701000-00013","article-title":"Role of oncogenes in resistance and killing by cancer therapeutic agents","volume":"9","author":"el-Deiry","year":"1997","journal-title":"Curr. Opin. Oncol."},{"issue":"19","key":"10.1016\/j.cbi.2010.02.002_bib58","first-page":"4285","article-title":"Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents","volume":"57","author":"O\u2019Connor","year":"1997","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12038-009-0013-7","article-title":"Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis","volume":"34","author":"Ganguly","year":"2009","journal-title":"J. Biosci."},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib60","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2008.11.017","article-title":"Papillomavirus E6 proteins","volume":"384","author":"Howie","year":"2009","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib61","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jmb.2007.09.031","article-title":"Activation of Cdc2 contributes to apoptosis in HPV E6 expressing human keratinocytes in response to therapeutic agents","volume":"374","author":"Liu","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"23","key":"10.1016\/j.cbi.2010.02.002_bib62","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1158\/0008-5472.CAN-05-1216","article-title":"Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo","volume":"65","author":"Disbrow","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bcp.2004.03.003","article-title":"Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines","volume":"68","author":"Efferth","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.cbi.2010.02.002_bib64","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.freeradbiomed.2004.06.023","article-title":"Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron","volume":"37","author":"Efferth","year":"2004","journal-title":"Free Radic. Biol. Med."},{"issue":"13","key":"10.1016\/j.cbi.2010.02.002_bib65","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1021\/bi00387a006","article-title":"Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action","volume":"26","author":"Sinha","year":"1987","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0006-2952(90)90705-P","article-title":"Cytochrome P450 reductase, antioxidant enzymes and cellular resistance to doxorubicin","volume":"40","author":"Singh","year":"1990","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.cbi.2010.02.002_bib67","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ijc.2910580512","article-title":"Characterization of a human bladder cancer cell line selected for resistance to mitomycin C","volume":"58","author":"Xu","year":"1994","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.cbi.2010.02.002_bib68","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1021\/tx030050s","article-title":"Endogenously generated hydrogen peroxide is required for execution of melphalan-induced apoptosis as well as oxidation and externalization of phosphatidylserine","volume":"17","author":"Matsura","year":"2004","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.cbi.2010.02.002_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/138945006776359412","article-title":"Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells","volume":"7","author":"Efferth","year":"2006","journal-title":"Curr. Drug Targets"},{"issue":"7137","key":"10.1016\/j.cbi.2010.02.002_bib70","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nature05630","article-title":"Multiple molecular mechanisms for multidrug resistance transporters","volume":"446","author":"Higgins","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cbi.2010.02.002_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1566524013364194","article-title":"The human ATP-binding cassette transporter genes: from the bench to the bedside","volume":"1","author":"Efferth","year":"2001","journal-title":"Curr. Mol. Med."},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib72","first-page":"237","article-title":"Chemotherapy-induced resistance by ATP-binding cassette transporter genes","volume":"1775","author":"Gillet","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.cbi.2010.02.002_bib73","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/bcmd.2002.0492","article-title":"Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells","volume":"28","author":"Efferth","year":"2002","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710000700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710000700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:19:59Z","timestamp":1757855999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279710000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0009279710000700"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2010.02.002","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors determining sensitivity or resistance of tumor cell lines towards artesunate","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2010.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}